This paper provides a comprehensive overview of stereotactic breast biopsy as a minimally invasive alternative to traditional wire-localized surgical biopsy for the diagnosis of nonpalpable mammographic abnormalities. It begins with background on breast cancer prevalence and the role of mammography in early detection, then explains in detail how the stereotactic procedure is performed, including both the Mammotome and Advanced Breast Biopsy Instrumentation (ABBI) techniques. The paper also addresses accuracy, patient benefits, limitations, and potential complications. A final section discusses the complexities of medical coding for the procedure, including relevant CPT and ICD-9-CM codes and billing considerations.
Breast cancer is a very common disease and is the most common type of cancer in women, although it is not unheard of for a man to develop it as well. About one woman in eight — approximately 12% of all women — will develop breast cancer at some point in her life, and roughly 50,000 women die from the disease every year. Early detection is an important factor in the successful treatment of breast cancer. Through monthly self-breast exams, periodic professional exams, and mammography, breast cancer can usually be detected at an early stage. With early detection, treatment is more effective and patient outcomes improve significantly.
Mammograms are an essential part of the screening process. Although some controversy exists, the generally accepted recommendations for mammography include a screening mammogram at age 35, annual or biennial mammograms between ages 40 and 50, and an annual mammogram after age 50. A mammogram does not, by itself, make a diagnosis of cancer — it can identify changes that may represent cancer, changes that are often too small to be felt on physical examination. When such changes require further diagnosis, they have traditionally been removed through surgical excision following wire localization. In that traditional approach, the mammogram is used as a guide for placing a thin wire near the abnormality, allowing the surgeon to identify the area during the operation and remove the surrounding tissue in the operating room.
Stereotactic breast biopsy has been developed as an alternative to wire-localized biopsy for mammographic abnormalities that cannot be felt with the hands. As of the time of this writing, approximately twenty percent of breast biopsies are performed stereotactically, and it is anticipated that this proportion will continue to grow. The procedure has become popular because it is highly accurate and minimizes the amount of cutting required.
After the patient is identified as having a nonpalpable mass on mammogram, she is prepared for the procedure in the standard manner. The patient lies face-down on the stereotactic table with the breast suspended through a hole in the table surface. The breast is then placed in compression, much as it would be during a standard mammogram. Special digital X-rays — which use significantly less radiation than traditional mammograms — are obtained of the affected breast. Images are captured at two 15-degree angles from the center and displayed on a computer monitor, allowing the physician to identify the lesion in three dimensions. The surgeon then uses these computer images to guide a biopsy needle to the precise coordinates of the abnormal area as indicated by the three-dimensional picture.
Once the suspicious area is reached, breast tissue can be removed using one of two methods. The first is called the Mammotome procedure, which uses a large-bore needle to remove cores of tissue through a small incision of only 2–3 mm. Multiple core samples are usually taken. The major advantage of the Mammotome procedure is that it leaves virtually no scar.
The second method is the Advanced Breast Biopsy Instrumentation (ABBI) procedure. This device removes a larger core of tissue, typically 5–20 mm in diameter, and is capable of removing the entire lesion from the breast. The ABBI procedure can provide a more accurate diagnosis and also help indicate whether the entire suspicious area was successfully excised.
Both types of stereotactic breast biopsy are performed under local anesthesia, meaning the patient is awake throughout the procedure. Patients generally report minimal discomfort during and after the biopsy and are usually able to resume normal activities by the following day.
Studies have shown that stereotactic breast biopsy can be as accurate as open surgical biopsy when performed by a skilled practitioner. The benefits of the procedure include less patient discomfort, quicker recovery, decreased scarring, and lower cost compared to traditional open surgical biopsy. Additionally, while traditional mammographic-directed biopsies require that a lesion be visible on two views, stereotactic techniques allow abnormalities seen on only one view to be sampled.
"Accuracy, patient recovery, and procedure constraints"
"CPT codes and billing guidance for stereotactic procedures"
Always verify citation format against your institution’s current style guide requirements.